We previously reported that five out of seven (71%) of BRAFV600E mutant pediatric grade II-IV astrocytoma have homozygous deletion of CDKN2A, which encodes the p16 tumor suppressor [6]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).